Morpholino

MO2-slc9a3.2

ID

ZDB-MRPHLNO-120123-4

Name

MO2-slc9a3.2

Previous Names

None

Target

Sequence

5' - AGTAGAAAACGCCATATCAGAACGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-slc9a3.2

Expressed Gene	Anatomy	Figures
slc9a3.2	whole organism	Fig. S3 from Chang et al., 2013
slc12a10.2	NCC ionocyte	Fig. 3 from Chang et al., 2013

Phenotype

Phenotype resulting from MO2-slc9a3.2

Phenotype	Fish	Figures
ammonium transmembrane transport decreased process quality, abnormal	AB + MO2-slc9a3.2	Fig. 7 from Shih et al., 2012
head NCC ionocyte increased amount, abnormal	AB + MO2-slc9a3.2	Fig. 3 from Chang et al., 2013
NCC ionocyte increased amount, abnormal	AB + MO2-slc9a3.2	Fig. 3 from Chang et al., 2013
sodium ion homeostasis disrupted, abnormal	AB + MO2-slc9a3.2	Fig. 3 from Chang et al., 2013
sodium ion transport decreased process quality, abnormal	AB + MO2-slc9a3.2	Fig. 7 from Shih et al., 2012

Phenotype of all Fish created by or utilizing MO2-slc9a3.2

Phenotype	Fish	Conditions	Figures
sodium ion homeostasis disrupted, abnormal	AB + MO2-slc9a3.2	standard conditions	Fig. 3 from Chang et al., 2013
NCC ionocyte increased amount, abnormal	AB + MO2-slc9a3.2	standard conditions	Fig. 3 from Chang et al., 2013
ammonium transmembrane transport decreased process quality, abnormal	AB + MO2-slc9a3.2	standard conditions	Fig. 7 from Shih et al., 2012
head NCC ionocyte increased amount, abnormal	AB + MO2-slc9a3.2	standard conditions	Fig. 3 from Chang et al., 2013
sodium ion transport decreased process quality, abnormal	AB + MO2-slc9a3.2	standard conditions	Fig. 7 from Shih et al., 2012
sodium ion import across plasma membrane increased occurrence, abnormal	rhcgb^ot202/ot202 + MO2-slc9a3.2	low sodium	Fig. 3 from Zimmer et al., 2020
sodium ion import across plasma membrane increased occurrence, abnormal	rhcgb^ot202/ot202 + MO2-slc9a3.2	control	Fig. 3 from Zimmer et al., 2020

Citations